Editorial

July 3, 2026


New strategy to regulate immunopathogenic processes of glomerulonephritis
Ho Jun Chin
Kidney Res Clin Pract. 2026;45(5):645-646.

Editorial

May 11, 2026


The role of exercise as an adjunctive therapy in patients on maintenance hemodiafiltration: clinical benefits and implications
Moo Jun Kim, Hyo-Wook Gil
Kidney Res Clin Pract. 2026;45(5):647-649.

Editorial

July 30, 2025


Denosumab for kidney transplant recipients: clinical value and unresolved questions
Hye-Sun Park
Kidney Res Clin Pract. 2026;45(5):650-652.

Special Article

December 22, 2025


A position statement and recommendations for sustainable kidney care
Jihyun Yang, So Mi Kim, Eunjeong Kang, et al.
Kidney Res Clin Pract. 2026;45(5):653-667.

Review Article

June 2, 2026


Advances and unmet needs in the management of proliferative lupus nephritis: evidence, guidelines, and emerging therapies
Sunhwa Lee
Kidney Res Clin Pract. 2026;45(5):668-676.

Review Article

July 3, 2026


Evolving therapeutic landscape of immunoglobulin A nephropathy: targeted immune pathways and novel therapies
Yaerim Kim
Kidney Res Clin Pract. 2026;45(5):677-688.

Original Article

December 16, 2025


Outpatient visit intervals in chronic kidney disease: adherence to Kidney Disease: Improving Global Outcomes recommendations and determinants of variation
Somi Kim, Ga Young Heo, Cheol Ho Park, et al.
Kidney Res Clin Pract. 2026;45(5):689-701.

Original Article

July 3, 2026


Remission of hematuria is associated with a better prognosis in immunoglobulin A nephropathy
Geo Neul Park, MinSung Lee, Seon Min Kim, et al.
Kidney Res Clin Pract. 2026;45(5):702-712.

Original Article

December 8, 2025


Frailty-related factors and 1-year renal function change after sodium-glucose cotransporter-2 inhibitors in elderly chronic kidney disease patients
Hye-Mi Noh, Sei Hong Min, Hyung-Seok Lee, et al.
Kidney Res Clin Pract. 2026;45(5):713-723.

Original Article

June 11, 2026


Development and external validation of an explainable machine learning model for predicting chronic kidney disease progression in the Korean population
Hojun Yu, Yon Su Kim, Kwon Wook Joo, et al.
Kidney Res Clin Pract. 2026;45(5):724-742.

Original Article

December 20, 2024


Association between obstructive sleep apnea and albuminuria in Korean adults: a nationwide populationbased study
Yeojin Yu, Kyungdo Han, Kyu-na Lee, et al.
Kidney Res Clin Pract. 2026;45(5):743-753.

Original Article

April 25, 2025


Exercise as an adjunctive therapy for patients on maintenance hemodiafiltration
Jessica L. F. Andrade, Ayden T. Heitmann, Miguel K. Rodrigues, et al.
Kidney Res Clin Pract. 2026;45(5):754-766.

Original Article

March 20, 2026


Facility-level comorbidity burden and cardiovascular outcome in patients undergoing hemodialysis
Hyo Jeong Kim, Seok-Jae Heo, Jung Tak Park, et al.
Kidney Res Clin Pract. 2026;45(5):767-777.

Original Article

July 8, 2026


Efficacy, safety, and dose selection of efepoetin alfa in anemic patients on maintenance dialysis: a phase 2, randomized, multicenter, active-controlled trial
Eun Jeong Ko, Mi-Sun Byun, Chul Woo Yang, et al.
Kidney Res Clin Pract. 2026;45(5):778-791.

Original Article

January 17, 2025


Microstructural and functional connectivity changes of decision-related brain networks in end-stage kidney disease patients undergoing peritoneal dialysis
Jingjing Yin, Dongxue Luo, Shuhua Ma, et al.
Kidney Res Clin Pract. 2026;45(5):792-806.

Original Article

March 25, 2026


Xerosis elevates the risk of catheter-related infections in peritoneal dialysis patients
Jeong Geon Lee, Jihee Lim, Nam-Jun Cho, et al.
Kidney Res Clin Pract. 2026;45(5):807-817.

Original Article

November 18, 2024


Effectiveness and safety of denosumab on osteoporosis treatment in kidney transplant recipients
Jin Kyung Kwon, Yaerim Kim, Jin Hyuk Paek, et al.
Kidney Res Clin Pract. 2026;45(5):818-828.

Original Article

November 29, 2024


Combined nutcracker syndrome and glomerulonephritis in pediatric patients: a single-center retrospective case series
So Hyun Ki, Min Hwa Son, Hyung Eun Yim
Kidney Res Clin Pract. 2026;45(5):829-841.

Images in Practice

June 17, 2026


A hidden nonfunctioning kidney in autosomal dominant polycystic kidney disease
Yeonsoon Jung, Ye Na Kim, Ho Sik Shin, et al.
Kidney Res Clin Pract. 2026;45(5):842-843.

Letter to the Editor

July 28, 2026


Before new variants in genes associated with hematuria or proteinuria can be classified as causative, their pathogenicity must be demonstrated
Sounira Mehri, Josef Finsterer
Kidney Res Clin Pract. 2026;45(5):844-845.

Letter to the Editor

August 4, 2026


Response to the letter regarding “Genetic diagnosis of hereditary kidney disease in pediatric patients through whole-exome sequencing and mitochondrial DNA analysis”
Jiyoung Oh, Keumwha Lee, Dongju Won, et al.
Kidney Res Clin Pract. 2026;45(5):846-847.
Editorials
New strategy to regulate immunopathogenic processes of glomerulonephritis
Ho Jun Chin
Kidney Res Clin Pract. 2026;45(5):645-646.   Published online July 3, 2026
Special Article
A position statement and recommendations for sustainable kidney care
Jihyun Yang, So Mi Kim, Eunjeong Kang, Harin Rhee, Jwa-Kyung Kim, Jung-Kook Wi, Ju-Young Moon, Yoosun Joo, Yohan Park, Young-Hwan Hwang, Kyungho Choi, Younglim Kho, Katherine Barraclough, Gangjee Ko
Kidney Res Clin Pract. 2026;45(5):653-667.   Published online December 22, 2025
The Korean Society of Nephrology has embraced the principle of “Green Nephrology” and launched campaigns addressing environmental sustainability in kidney care. These include initiatives to monitor resource usage, reduce waste generation in treatment facilities, and minimize dialysis-related environmental effects. The Society aims to raise awareness about the environmental impact of kidney disease and its treatments while emphasizing the importance of...
Review Articles
Advances and unmet needs in the management of proliferative lupus nephritis: evidence, guidelines, and emerging therapies
Sunhwa Lee
Kidney Res Clin Pract. 2026;45(5):668-676.   Published online June 2, 2026
Proliferative lupus nephritis is a major cause of kidney failure and premature mortality in patients with systemic lupus erythematosus. Although mycophenolate-based regimens and cyclophosphamide remain standard induction therapies, up to one-third of patients have refractory disease, and many fail to achieve a complete renal response, as demonstrated in the ASPREVA, AURORA, and BLISSLN trials. Treatment-related toxicity—particularly from prolonged glucocorticoid exposure—contributes...
Evolving therapeutic landscape of immunoglobulin A nephropathy: targeted immune pathways and novel therapies
Yaerim Kim
Kidney Res Clin Pract. 2026;45(5):677-688.   Published online July 3, 2026
Recent advances in the understanding of immunoglobulin A nephropathy (IgAN) pathogenesis have led to a rapidly expanding therapeutic landscape for the condition. Treatments have historically relied on optimized supportive care aimed at controlling blood pressure and reducing proteinuria through blockading of the renin-angiotensin system and inhibition of the sodium glucose cotransporter 2. Growing insights into immune dysregulation, mucosal immunity, complement...
Original Articles
Outpatient visit intervals in chronic kidney disease: adherence to Kidney Disease: Improving Global Outcomes recommendations and determinants of variation

Somi Kim, Ga Young Heo, Cheol Ho Park, Jung Tak Park, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang, Song-Hee Kim, Hyung Woo Kim
Kidney Res Clin Pract. 2026;45(5):689-701.   Published online December 16, 2025
Background: Chronic kidney disease (CKD) is a major global health problem owing to its progressive nature, complications, and substantial healthcare burden. The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend outpatient visit intervals based on CKD severity; however, adherence to these recommendations and the factors influencing the visit interval remain unclear. Methods: This retrospective observational study included 13,621 patients with...
Remission of hematuria is associated with a better prognosis in immunoglobulin A nephropathy

Geo Neul Park, MinSung Lee, Seon Min Kim, Yoonwon Choi, Soo Jeong Choi, Moo Yong Park, Jin Kuk Kim, Byung Chul Yu
Kidney Res Clin Pract. 2026;45(5):702-712.   Published online July 3, 2026
Background: The clinical significance of hematuria in immunoglobulin A nephropathy (IgAN) remains unclear. We defined remission of hematuria using stricter yet more intuitive criteria than those in previous studies and evaluated its association with prognosis in IgAN. Methods: This retrospective, multicenter, observational study enrolled 403 patients with IgAN. Hematuria remission was defined as hematuria persisting for at least 3 months...
Frailty-related factors and 1-year renal function change after sodium-glucose cotransporter-2 inhibitors in elderly chronic kidney disease patients

Hye-Mi Noh, Sei Hong Min, Hyung-Seok Lee, Sung Gyun Kim, Jun Goo Kang, Jwa-Kyung Kim
Kidney Res Clin Pract. 2026;45(5):713-723.   Published online December 8, 2025
Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are first-line therapy for chronic kidney disease (CKD). However, evidence regarding their safety and efficacy in frail elderly patients remains limited. This study evaluated the impact of frailty-related factors on renal outcomes in elderly CKD patients treated with SGLT2i. Methods: We retrospectively analyzed 302 elderly CKD patients (≥65 years) newly prescribed SGLT2i. Four frailty-related factors...
Development and external validation of an explainable machine learning model for predicting chronic kidney disease progression in the Korean population

Hojun Yu, Yon Su Kim, Kwon Wook Joo, Kook-Hwan Oh, Dong Ki Kim, Hajeong Lee, Seung Seok Han, Eunjeong Kang, Sehoon Park, Byoungjun Jeon, Yong Chul Kim
Kidney Res Clin Pract. 2026;45(5):724-742.   Published online June 11, 2026
Background: Current risk stratification models, such as the Kidney Failure Risk Equation (KFRE), exhibit variable performance across ethnic groups and fail to capture dynamic clinical trajectories. This study aimed to develop and validate a Korean-specific machine learning (ML) model for predicting chronic kidney disease (CKD) progression using an ensemble approach. Methods: We used electronic health records from Seoul National University...
Association between obstructive sleep apnea and albuminuria in Korean adults: a nationwide populationbased study

Yeojin Yu, Kyungdo Han, Kyu-na Lee, Jung Hun Koh, Young Sun Shin, Jeong Min Cho, Minsang Kim, Min Woo Kang, Seong Geun Kim, Sehyun Jung, Semin Cho, Hyuk Huh, Eunjeong Kang, Sehoon Park, Yaerim Kim, Kwon Wook Joo, Dong Ki Kim, Soojin Lee
Kidney Res Clin Pract. 2026;45(5):743-753.   Published online December 20, 2024
Background: Obstructive sleep apnea (OSA) is a sleep disorder associated with an increased risk of cardiovascular and metabolic complications. Albuminuria, an early marker of kidney damage, is a proposed risk factor for OSA and its adverse outcomes. The study explored the association between OSA and albuminuria in Korean adults. Methods: We screened participants from the cross-sectional Korean National Health and...
Exercise as an adjunctive therapy for patients on maintenance hemodiafiltration

Jessica L. F. Andrade, Ayden T. Heitmann, Miguel K. Rodrigues, Dave K. Marchand, Adelson M. Rodrigues, Bruno P. Biluca, Rene Freitas, Thiago Reis, Miguel A. Goes, Mayron F. Oliveira
Kidney Res Clin Pract. 2026;45(5):754-766.   Published online April 25, 2025
Background: Fatigue and sedentarism are common in kidney disease and dialysis treatment. Although hemodiafiltration effectively removes solutes and improves mortality, the influence of exercise as an adjunct therapy on maintenance hemodiafiltration programs remains understudied. Methods: A multicenter 6-month study was assessed comparing individuals with chronic kidney disease enrolled in exercise training (exercise group) during dialysis (intradialytic vs. interdialytic) compared to...
Facility-level comorbidity burden and cardiovascular outcome in patients undergoing hemodialysis

Hyo Jeong Kim, Seok-Jae Heo, Jung Tak Park, Ga Young Heo, Kyung Won Kim, Yong Uk Kwon, Soo Hyun Kim, Gui Ok Kim, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang, Hyung Woo Kim
Kidney Res Clin Pract. 2026;45(5):767-777.   Published online March 20, 2026
Background: The impact of facility-level comorbidity burden on the prognosis of hemodialysis patients remains unclear. This study aimed to investigate the association between facility-level comorbidity burden and hemodialysis outcomes. Methods: We examined 15,481 participants receiving hemodialysis at primary clinics participating in the Periodic Hemodialysis Quality Assessment by Health Insurance Review and Assessment Service in Korea. Facility-level comorbidity burden, defined as...
Efficacy, safety, and dose selection of efepoetin alfa in anemic patients on maintenance dialysis: a phase 2, randomized, multicenter, active-controlled trial

Eun Jeong Ko, Mi-Sun Byun, Chul Woo Yang, Sug Kyun Shin, Hyung Wook Kim, Byung Chul Shin, Seok Joon Shin, Hyeong Cheon Park, Young Sun Kang, Sang-Ho Lee, Ho Cheol Song, Su Hyun Kim, Ki Young Na, Young-Il Jo, Won Kim, Eun Young Seong, Yong-Lim Kim, Hyunjoo Ryu, Heewon Kim, Yoon-Jeong Choi, Byung Ha Chung
Kidney Res Clin Pract. 2026;45(5):778-791.   Published online July 8, 2026
Background: Efepoetin alfa (GC1113, GX-E2) is a long-acting recombinant human erythropoietin fused to a hybrid fragment crystallizable (hyFc) that prolongs systemic exposure via neonatal Fc receptor-mediated recycling. This active-controlled phase 2 trial evaluated efepoetin alfa and informed phase 3 starting dose selection for chronic kidney disease-related anemia in dialysis patients. Methods: In this multicenter, open-label, active-controlled trial, adults on hemodialysis...
Microstructural and functional connectivity changes of decision-related brain networks in end-stage kidney disease patients undergoing peritoneal dialysis

Jingjing Yin, Dongxue Luo, Shuhua Ma, Chudan Cai, Xiaoyan Shi, Yanqiang Peng, Jianwei Peng, Lingyu Chen, Yanmin Zheng, Ruiwei Guo, Zelin Zhuang, Zhirong Lin, Lei Xie
Kidney Res Clin Pract. 2026;45(5):792-806.   Published online January 17, 2025
Background: We aimed to explore changes in decision-related brain microstructure, brain functional activities, and functional connectivity, and their correlations with cognitive function in end-stage kidney disease (ESKD) patients undergoing peritoneal dialysis (PD). Furthermore, the impact of dialysis on these changes was examined. Methods: Thirty ESKD patients undergoing PD, 20 predialysis patients with chronic kidney disease (CKD) stage 5 (predialysis CKD...
Xerosis elevates the risk of catheter-related infections in peritoneal dialysis patients

Jeong Geon Lee, Jihee Lim, Nam-Jun Cho, Samel Park, Hyo-Wook Gil, Hoonhee Seo, Ho-Yeon Song, Sun-Hee Park, Kook-Hwan Oh, Yong-Lim Kim, Brian A. Bieber, Ronald L. Pisoni, Eun Young Lee
Kidney Res Clin Pract. 2026;45(5):807-817.   Published online March 25, 2026
Background: Catheter-related infections, such as exit-site infection and tunnel infection, are major complications in peritoneal dialysis (PD) patients, affecting their prognosis. This study investigates the association between skin conditions and catheter-related infections. Methods: Data from two distinct sources were analyzed: (1) 626 PD patients in the Korean arm of the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) and (2)...
Effectiveness and safety of denosumab on osteoporosis treatment in kidney transplant recipients

Jin Kyung Kwon, Yaerim Kim, Jin Hyuk Paek, Kyubok Jin, Seungyeup Han, Woo Yeong Park
Kidney Res Clin Pract. 2026;45(5):818-828.   Published online November 18, 2024
Background: Denosumab has been reported to improve bone mineral density (BMD), but the clinical impact of denosumab on osteoporosis in kidney transplant recipients (KTRs) remains controversial. Methods: We analyzed 98 KTRs who used denosumab from 2018 to 2023. We investigated the change in BMD, laboratory findings, complications of denosumab, fracture risk assessment tool (FRAX) score, acute rejection within 1 year, and...
DOI: https://doi.org/10.23876/j.krcp.24.168    [Epub ahead of print]
Combined nutcracker syndrome and glomerulonephritis in pediatric patients: a single-center retrospective case series

So Hyun Ki, Min Hwa Son, Hyung Eun Yim
Kidney Res Clin Pract. 2026;45(5):829-841.   Published online November 29, 2024
Background: Nutcracker syndrome (NCS) has been reported to coexist with various glomerulonephritis (GN). This study investigated clinical features of NCS combined with GN in a pediatric case series and the possible relationship between these two conditions. Methods: Clinical and pathologic findings of 15 children with NCS and biopsy-proven GN were analyzed. NCS was diagnosed with renal Doppler ultrasonography, abdominal computed...
Images in Practice
A hidden nonfunctioning kidney in autosomal dominant polycystic kidney disease
Yeonsoon Jung, Ye Na Kim, Ho Sik Shin, Hark Rim
Kidney Res Clin Pract. 2026;45(5):842-843.   Published online June 17, 2026
Letters to the Editor
Before new variants in genes associated with hematuria or proteinuria can be classified as causative, their pathogenicity must be demonstrated
Sounira Mehri, Josef Finsterer
Kidney Res Clin Pract. 2026;45(5):844-845.   Published online July 28, 2026

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736    Fax: +82-2-3486-8737    E-mail: registry@ksn.or.kr                

Copyright © 2026 by The Korean Society of Nephrology.

Developed in M2PI

Close layer